Dry Powder Inhaler (DPI) Joins CanNegev Incubator in Yeruham

Share on facebook
Share on twitter
Share on linkedin
Share on whatsapp
Share on email

MAR

2022

CanNegev is pleased to announce that Dry Powder Inhaler (DPI) has joined the CanNegev Incubator program. This follows approval by the Israel Innovation Authority (IAA).

CanDI DPI is a breakthrough in delivering medications and cannabinoids to the lungs by dry powder inhalator. Suitable for any generic and systemic medical powder drugsEasy to use for all patients.

We wish CanDI every success!

Apply

Interested in joining CanNegev or receiving more information? Please complete the form below and a team member will get back to you as soon as possible.

Add a file here